Skip to main content
Premium Trial:

Request an Annual Quote

Iconix Signs Chemogenomics Deal with Millennium

NEW YORK, Oct. 21 (GenomeWeb News) - Millennium Pharmaceuticals has selected Iconix Pharmaceuticals to provide chemogenomic profiling and analytical services for Millennium's drug discovery programs, Iconix said today.

Millennium will use Iconix's chemogenomics platform for drug candidate selection and optimization. Iconix said it would use biomarkers of drug pathology and mechanism from its Drug Signature collection of predictive biomarkers to profile Millennium's compounds.

Financial details of the agreement were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.